The estimated Net Worth of Equity Opportunities Fund, ... is at least $127 millió dollars as of 30 June 2010. Equity Fund owns over 23,824,451 units of Sunesis Pharmaceuticals Inc stock worth over $126,746,079 and over the last 14 years Equity sold SNSS stock worth over $0.
Equity has made over 1 trades of the Sunesis Pharmaceuticals Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently Equity bought 23,824,451 units of SNSS stock worth $6,670,846 on 30 June 2010.
The largest trade Equity's ever made was buying 23,824,451 units of Sunesis Pharmaceuticals Inc stock on 30 June 2010 worth over $6,670,846. On average, Equity trades about 23,824,451 units every 0 days since 2010. As of 30 June 2010 Equity still owns at least 23,824,451 units of Sunesis Pharmaceuticals Inc stock.
You can see the complete history of Equity Fund stock trades at the bottom of the page.
Over the last 19 years, insiders at Sunesis Pharmaceuticals Inc have traded over $89,557,714 worth of Sunesis Pharmaceuticals Inc stock and bought 191,253,594 units worth $84,730,221 . The most active insiders traders include Forest Baskett, Scott D Sandell és Peter J Barris. On average, Sunesis Pharmaceuticals Inc executives and independent directors trade stock every 67 days with the average trade being worth of $14,060,191. The most recent stock trade was executed by Tina Gullotta on 29 May 2020, trading 6,000 units of SNSS stock currently worth $1,980.
Sunesis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: